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drainage after thoracic aortic endograft
Charles J. Keith Jr, Marc A. Passman, Martin J. Carignan, Gaurav M. Parmar,
Shardul B. Nagre, Mark A. Patterson, Steven M. Taylor, William D. Jordan Jr
Background: Spinal cord ischemia (SCI) remains a signiﬁcant concern in
patients undergoing endovascular repair involving the thoracic aorta
(thoracic endovascular aortic repair [TEVAR]). Perioperative lumbar spinal
drainage has been widely practiced for open repair, but there is no
consensus treatment protocol using lumbar drainage for SCI associated
with TEVAR. This study analyzes the efﬁcacy of an institutional protocol
using selective lumbar drainage reserved for patients experiencing SCI
following TEVAR.
Methods: A prospectively maintained registry was reviewed to identify all
patients who underwent TEVAR from January 2000 through June 2010.
Preoperative characteristics, intraoperative details, and outcomes,
including neurologic deﬁcit and mortality at 30 days and 1 year were
determined based on reporting standards. Patients developing symptoms
of SCI in the postoperative setting were compared with those without
neurologic symptoms. SCI patients who received selective lumbar drainage
were grouped based on resolution of neurologic function, with risk factors
and outcomes of these subgroups analyzed with c2, t test, logistic
regression, and analysis of variance (ANOVA).
Results: Two hundred seventy-eight TEVARs were performed on 251
patients. Twelve patients accounting for 12 TEVARs were excluded from
analysis: 5 patients experienced SCI preoperatively, 4 patients were
drained preoperatively, 2 expired intraoperatively, and 1 procedure was
aborted. Of the remaining 266 procedures in 239 patients, 16 (6.0%)
developed SCI within the 30-day postoperative period. Risk factors for SCI
reaching statistical signiﬁcance included length of aortic coverage (P =
.036), existence of infrarenal aortic pathology (P = .026), and history of
stroke (P = .043). Stent graft coverage of the left subclavian artery origin
was required in 28.9% (n = 77) and was not associated with SCI (P = .52).
Ten of 16 post-TEVAR SCI patients received selective postoperative lumbar
drains and were categorized based on resolution of symptoms into
complete resolution (n = 3; 30%), partial resolution (n = 4; 40%), and no
resolution (n = 3; 30%). No patient characteristics or risk factors reached
signiﬁcance in comparison of lumbar drained patients and nondrained
patients. All seven drained patients without complete resolution of SCI
died within the ﬁrst year after surgery, while all three of the complete
responders survived (P = .017). In patients with SCI, increased all-cause
mortality was observed at 1 year (56.3% vs 20.4%; P = .003).
Conclusions: A protocol utilizing selective postoperative lumbar spinal
drainage can be used safely for patients developing SCI after TEVAR with
acceptably low permanent neurologic deﬁcit, although overall survival ofq Full articles available online at www.jvascsurg.org
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doi:10.1016/S1078-5884(11)00756-8patients experiencing SCI after TEVAR is diminished relative to non-SCI
patients.
Robotic-assisted aortic surgery with and without minilaparotomy
for complicated occlusive disease and aneurysm
Judith C. Lin, Sanjeev A. Kaul, Akshay Bhandari, Edward L. Peterson, James
O. Peabody, Mani Menon
Objective: Published reports of robotic-assisted aortic surgery involve
a combination of laparoscopy for aortic dissection and a robotic system for
vascular reconstruction. The objective of this study is to determine the
feasibility and advantage of a total robotic-assisted aortic dissection and
vascular reconstruction vs robotic-assisted aortic procedures for aortoiliac
occlusive disease (AIOD) and abdominal aortic aneurysm (AAA).
Methods: From February 2006 to August 2010, 21 patients were selected
for robotic-assisted aortic procedures: aortobifemoral bypass in 12, AAA
repair in 6, iliac aneurysm repair in 1, and ligation of type II endoleak after
endovascular aneurysm repair in 2. Inclusion criteria included AAA >5 cm,
iliac aneurysm >3 cm, and AIOD TransAtlantic InterSociety Classiﬁcation
(TASC) C or D lesions. The da Vinci S Surgical System (Intuitive Surgical Inc,
Sunnyvale, Calif) was used for the abdominal aortic dissection in all cases
and for the aortic anastomosis in three cases.
Results: The 21 patients (6 women, 15 men) were an average age of 65.7
years (range, 44-86 years), had a body mass index (BMI) of 27.23 kg/m2,
and 90.4% were American Society of Anesthesiologists (ASA) class 3 or 4.
Robotic dissection of the abdominal aorta was successful in 20 patients
(95.2%). One patient required full conversion to open AAA repair due to
trocar injury. Of the remaining 20 patients, the average robotic dissection
time of the infrarenal aorta was 113.1 minutes, and the average aortic
clamp time was 86 minutes. The procedure in 15 patients was performed
with a minilaparotomy using an average abdominal incision of 13 cm to
implant the Dacron or polytetraﬂuoroethylene graft. Five patients under-
went a total robotic-assisted procedure with robotic aortic reconstruction
or ligation of a type II endoleak. The 30-day survival rate was 100%. Median
length of stay was 7.5 days. All grafts were patent at a median follow-up of
32.0 months.
Conclusions: For aortic procedures completed total robotically without an
abdominal incision, the estimated blood loss was signiﬁcantly less than in
robotic-assisted procedures with a minilaparotomy. In these selected
patients, robotic-assisted technology may be part of the armamentarium
for the vascular surgeon as another less invasive method for the treatment
of complicated occlusive disease or aneurysm.
Long-term follow-up of type II endoleak embolization reveals the
need for close surveillance
Timur P. Sarac, Connor Gibbons, Lina Vargas, Jane Liu, Sunita Srivastava,
James Bena, Tara Mastracci, Vikram S. Kashyap, Daniel Clair
Abstracts / European Journal of Vascular and Endovascular Surgery 43 (2012) 133e135134Objective: Aneurysm growth after endovascular aneurysm repair (EVAR)
in patients with type II endoleak is associated with adverse outcomes. This
study evaluated the long-term success of embolization of type II endoleaks
in preventing aneurysm sac growth.
Methods: We retrospectively reviewed outcomes of patients who under-
went infrarenal EVAR who were treated for a type II endoleak between
2000 and 2008. Computed tomography scans were evaluated for aneu-
rysm sac growth or shrinkage from the time of treatment of the endoleak.
The embolization material used, graft type, target vessel embolized, and
comorbidities were evaluated for their association with sac growth or
shrinkage.
Results:Ninety-ﬁve patients underwent 140 embolization procedures. The
mean time from EVAR to embolization was 26.1  22.2 months, and the
average increase in size of the aneurysm sac from EVAR to treatment was
0.7  0.5 cm. Patients underwent an average of 1.6  0.8 embolization
procedures after EVAR. Thirteen patients underwent initial simultaneous
embolization of two targets. Embolizationwas with glue (61%), coils (29%),
glue and coils (7%), and Gelfoam (3%; Pﬁzer Inc, New York, NY). No
abdominal aortic aneurysms (AAA) ruptured. Eight patients (8.4%)
underwent graft explant and open repair; 19 (20%) required two or more
embolization procedures. There was no difference in the target vessel
treated or the treatment used in halting sac expansion (>5 mm). Coil
embolization alone resulted in more second procedures. The 5-year
cumulative survival was 65% (95% conﬁdence interval [CI], 52%-77%),
freedom from explant was 89% (95% CI, 81%-97%), freedom from second
embolization was 76% (95% CI, 66%-86%), and freedom from sac expansion
>5 mm was 44% (95% CI 30%-50%). Univariable analysis identiﬁed
continued tobacco use (hazard ratio [HR], 2.30; 95% CI, 1.02-5.13; P = .04)
was associated with continued sac expansion, and hyperlipidemia (HR,
9.64; 95% CI, 2.22-41.86) was associated with patients requiring a second
embolization procedure.
Conclusions: Embolization of type II endoleaks is successful early in pre-
venting aneurysm sac growth and rupture after EVAR. However, a signiﬁ-
cant number of patients require more than one procedure, and at 5 years,
many patients who underwent embolization of a type II endoleak
continued to experience sac growth. Patients with hyperlipidemia who
undergo coil embolization are more likely to require a second emboliza-
tion procedure, and patients who smoke have a higher likelihood of AAA
sac expansion after embolization. Continued long-term surveillance is
necessary in this cohort of patients.
A new classiﬁcation scheme for treating blunt aortic injury
Benjamin W. Starnes, Rachel S. Lundgren, Martin Gunn, Samantha Quade,
Thomas S. Hatsukami, Nam T. Tran, Nahush Mokadam, Gabriel Aldea
Background: There are numerous questions about the treatment of blunt
aortic injury (BAI), including the management of small intimal tears, what
injury characteristics are predictive of death from rupture, and which
patients actually need intervention. We used our experience in treating
BAI during the past decade to create a classiﬁcation scheme based on
radiographic and clinical data and to provide clear treatment guidelines.
Methods: The records of patients admitted with BAI from 1999 to 2008
were retrospectively reviewed. Patients with a radiographically or opera-
tively conﬁrmed diagnosis (echocardiogram, computed tomography, or
angiography) of BAI were included. We created a classiﬁcation system
based on the presence or absence of an aortic external contour abnor-
mality, deﬁned as an alteration in the symmetric, round shape of the aorta:
(1) intimal tear (IT)dabsence of aortic external contour abnormality and
intimal defect and/or thrombus of <10 mm in length or width; (2) large
intimal ﬂap (LIF)dabsence of aortic external contour abnormality and
intimal defect and/or thrombus of 10 mm in length or width; (3) pseu-
doaneurysmdpresence of aortic external contour abnormality and con-
tained rupture; (4) rupturedpresence of aortic external contour
abnormality and free contrast extravasation or hemothorax at
thoracotomy.
Results: We identiﬁed 140 patients with BAI. Most injuries were pseu-
doaneurysm (71%) at the isthmus (70%), 16.4% had an IT, 5.7% had a LIF, and
6.4% had a rupture. Survival rates by classiﬁcation were IT, 87%; LIF, 100%;
pseudoaneurysm, 76%; and rupture, 11% (one patient). Of the ITs, LIFs, andpseudoaneurysms treated nonoperatively, none worsened, and 65%
completely healed. No patient with an IT or LIF died. Most patients with
ruptures lost vital signs before presentation or in the emergency depart-
ment and did not survive. Hypotension before or at hospital presentation
and size of the periaortic hematoma at the level of the aortic arch predicted
likelihood of death from BAI.
Conclusions: As a result of this new classiﬁcation scheme, no patient
without an external aortic contour abnormality died of their BAI. ITs can be
managed nonoperatively. BAI patients with rupture will die, and resources
could be prioritized elsewhere. Those with LIFs do well, and currently,
most at our institution are treated with a stent graft. If a pseudoaneurysm
is going to rupture, it does so early. Hematoma at the arch on computed
tomography scan and hypotension before or at arrival help to predict
which pseudoaneurysms need urgent repair.
Diabetes is not a predictor of outcome for carotid revascularization
with stenting as it may be for carotid endarterectomy
Gianbattista Parlani, Paola De Rango, Enrico Cieri, Fabio Verzini, Giuseppe
Giordano, Gioele Simonte, Giacomo Isernia, Piergiorgio Cao
Background: Diabetes is prevalent in most patients undergoing carotid
revascularization and is suggested as a marker of poor outcome after
carotid endarterectomy (CEA). Data on outcome of diabetic patients
undergoing carotid artery stenting (CAS) are limited. The aim of this study
was to investigate early and 6-year outcomes of diabetic patients under-
going carotid revascularization with CAS and CEA.
Methods: The database of patients undergoing carotid revascularization
for primary carotid stenosis was queried from 2001 to 2009. Diabetic
patients were deﬁned as those with established diagnosis and/or receiving
oral hypoglycemic or insulin therapy. Multivariate and Kaplan- Meier
analyses, stratiﬁed by type of treatment, were performed on perioperative
(30 days) and late outcomes.
Results: A total of 2196 procedures, 1116 by CEA and 1080 by CAS (29%
female, mean age 71.3 years), were reviewed. Diabetes was prevalent in
630 (28.7%). Diabetic patients were younger (P< .0001) and frequently had
hypertension (P = .018) or coronary disease (P = .019). Perioperative stroke/
death rate was 2.7% (17/630) in diabetic patients vs 2.3% (36/1566) in
nondiabetic, (P = .64); the rate was 3.4% in diabetic CEA group and 2.1% in
diabetic CAS group (P = .46). At multivariate analyses, diabetes was
a predictor of perioperative stroke/death in the CEA group (odds ratio [OR],
2.83; 95% conﬁdence interval [CI], 1.05-7.61; P = .04) but not in the CAS
group (P = .72). Six-year survival was 76.0% in diabetics and 80.8% in
nondiabetics (P = .15). Six-year late stroke estimates were 3.2% in diabetic
and 4.6% in nondiabetic patients (P = .90). The 6-year risk of restenosis was
similar (4.6% % vs 4.2%) in diabetic and nondiabetic patients (P = .56).
Survival, late stroke, and restenosis rates between diabetics and nondia-
betics were similar in CAS and CEA groups.
Conclusions: Diabetic patients are not at greater risk of perioperative
morbidity and mortality or late stroke after CAS, however, the perioper-
ative risk can be higher after CEA. This may help in selecting the appro-
priate technique for carotid revascularization in patients best suited for the
type of procedure.
Common femoral endovenectomy with iliocaval endoluminal
recanalization improves symptoms and quality of life in patients
with postthrombotic iliofemoral obstruction
David Vogel, Anthony J. Comerota, Mustafa Al-Jabouri, Zakaria I. Assi
Background: The postthrombotic syndrome is a debilitating condition
occurring in 30% to 50% of patients with lower extremity deep vein
thrombosis (DVT). Following iliofemoral DVT, however, postthrombotic
morbidity is especially severe, due to occlusion of the common femoral
vein (CFV) and iliac veins. While endoluminal recanalization appears
effective in restoring patency to the iliac venous system, infrainguinal
obstruction of the CFV remains a problem. The purpose of this study is to
report preliminary observations of common femoral endovenectomy and
intraoperative endoluminal recanalization of the iliac veins in patients
with incapacitating postthrombotic iliofemoral obstruction.
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endoluminal iliocaval recanalization. The Venous Clinical Severity Score
(VCSS), a validated tool to assess chronic venous disease, the Villalta scale,
a validated tool to quantify postthrombotic syndrome, the clinical classi-
ﬁcation of CEAP, and the Venous Insufﬁciency Epidemiological and
Economic Study-Quality of Life (VEINES-QOL)/Sym questionnaires were
completed preoperatively and readministered postoperatively at 8.8
months (mean).
Results: Five patients were followed for more than 6 months and form the
basis of the long-term analysis. All demonstrated signiﬁcant improvement
in their venous scores postoperatively. The VCSS preoperatively was 17 and
fell to 9.8 postoperatively (P = .02). The Villalta scale dropped from 13.6
preoperatively to 6.0 postoperatively (P = .002). The VEINES-QOL/Sym
questionnaire, a sensitive marker of patient quality of life and symptom
status, was improved (P = .01 and .02, respectively).
Conclusion: Chronic postthrombotic iliofemoral venous obstruction
treated with common femoral endovenectomy and endoluminal recana-
lization improves objective outcome measures of patients with chronic
postthrombotic obstruction. By restoring unobstructed venous drainage
through the CFV to the vena cava, patients' postthrombotic morbidity is
reduced and quality of life is improved.
Evaluation of quality of life over time among 453 patients with
hyperhidrosis submitted to endoscopic thoracic sympathectomy
Nelson Wolosker, José Ribas Milanes de Campos, Paulo Kauffman, Laert
Andrade de Oliveira, Marco Antonio Soares Munia, Fábio Biscegli Jatene
Objectives: Current data do not provide enough information on how
quality of life (QoL) evolves over time in cases of endoscopic thoracic
sympathectomy (ETS). The purpose of this study was to ascertain whether
the immediate improvement in QoL after the surgery was sustained until
the ﬁfth postoperative year.
Methods: This was a prospective, nonrandomized and uncontrolled study.
From March 2001 to December 2003, 475 consecutive patients with
hyperhidrosis submitted to ETS were included. A QoL questionnaire was
applied at the preoperative day, around the 30th postoperative day, and
after the ﬁfth year.
Results: After excluding 22 patients who did not answer all the questions,
we analyzed 453 patients. Their ages ranged from 11 to 57 years old, with
a mean of 25.3 + 7.9 years, including 297 female patients (65.6%). All
patients were assessed on three occasions: before surgery, around the 30th
postoperative day, and after the ﬁfth postoperative year. The QoL before
surgery was considered to be poor or very poor for all patients. The QoL
around 30 days after surgery was better in 412 patients (90.9%), the same
in 27 patients (6.0%), and worse in 14 patients (3.1%). After 5 years, 409
patients (90.3%) were better, 27 (6.0%) were the same, and 14 (3.1%) were
worse. There were no differences between these postoperative times
according to the McNemar statistical test.Conclusion: The patients had an immediate improvement in QoL after ETS,
and this improvement was sustained until the ﬁfth postoperative year.
Management and prognosis of nonpulmonary large arterial disease
in 25 patients with Behçet disease from a single center
Hasan Tuzun, Emire Seyahi, Caner Arslan, Vedat Hamuryudan, Kazim
Besirli, Hasan Yazici
Objective: The purpose of this study was to evaluate and report our
treatment policies in the management of nonpulmonary arterial aneu-
rysms in Behçet disease and to assess the prognosis in a cohort of 25
patients diagnosed between 1996 and 2007 by formally reassessing their
outcome at the present time.
Methods: We identiﬁed 25 patients (24 men/1 woman) with Behçet
disease with nonpulmonary aneurysms (n = 23) or occlusions (n = 2)
between 1996 and 2007. All patients fulﬁlled the International Study
Group Criteria for Behçet disease. Aneurysms were demonstrated with
contrast-enhanced computed tomography (CT) or magnetic resonance
angiography (MRA) after ﬁrst-line ultrasonography. Standard surgical
procedures were carried out in 22 patients. One patient with a non-
ruptured saccular aortic aneurysm and 2 patients with carotid aneurysms
were managed only medically. For the patients with aneurysms located in
the aortic bifurcation, we preferred aorto-bi-iliac bypasses; for the six
extremity aneurysms, wewere able to ligate the arteries; and for the other
10 extremity aneurysms we used polytetraﬂuoroethylene (PTFE) grafts for
bypass procedures. All patients received immunosuppression with cyclo-
phosphamide and corticosteroids before the operation and were
continued in the postoperative period. All patients were examined
between January and December 2010 paying special attention for new and
anastomotic aneurysms and graft patency.
Results: There was one death and 1 patient was lost to follow-up. The
remaining 23 patients (92%) were under follow-up after amean of 7.4 2.9
years after their operation. Four PTFE grafts (40%) inserted for extremity
aneurysms occluded with no disabling consequences. Also, 6 patients who
were treated with ligation postoperatively began to complain of mild to
moderate claudication. In 2 patients, aneurysms recurred at the anasto-
motic site, whereas in 3 patients, new aneurysms developed at other sites.
Conclusion: The surgical management of large, nonpulmonary arterial
disease of Behçet disease is currently quite satisfactory. When the false
aneurysm is in the infrarenal aorta, aorto-bi-iliac bypass is the preferred
surgical intervention. Extremity aneurysms can be treated with synthetic
graft insertion. In selected cases, ligation can give satisfactory results;
however, postoperative claudication is common. In some patients with
small intact saccular aneurysms, surgery may not be necessary. Patients
must be prescribed immunosuppressive therapy with cyclophosphamide
and corticosteroids before and after the surgical intervention in order to
avoid Behçet disease activation.
